Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
- Research-oriented. Usually for universities and research institutions
- Possible fit: mentions development
- Open to: Public Agency, Nonprofit, Business, Tribal Government, Higher Education, Other
- Federal: usually nationwide. Check the listing for location limits